Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
England Securities is a U.S. registered broker-dealer that operates as the securities arm of England & Company, an independent middle-market investment banking and advisory firm. The firm provides M&A advisory, private capital raising, financial restructuring, fairness opinions, and other strategic advisory services. While it advises clients across several sectors including healthcare, it is not itself a life sciences, biotech, pharma, or healthcare operating company. Its role in healthcare is as a financial advisor to companies and investors in the sector rather than as a drug developer, medical technology developer, or healthcare services provider. England & Company states that securities products and services in the United States are offered through England Securities, LLC.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on England Securities.